Patents by Inventor Karen K. Yamamoto

Karen K. Yamamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for following the progress of prostate cancer
    Patent number: 7507549
    Abstract: This invention provides cDNA encoding a prostate-cancer specific marker, Repro-PC-1.0, Repro-PC-1.0 polypeptides and methods for use in diagnosis and therapy.
    Type: Grant
    Filed: July 19, 2004
    Date of Patent: March 24, 2009
    Assignee: Siemens Healthcare Diagnostices, Inc.
    Inventors: Cynthia K. French, Karen K. Yamamoto, A. Said El Shami
  • Prostate cancer-specific marker
    Patent number: 6900022
    Abstract: This invention provides cDNA encoding a prostate-cancer specific marker, Repro-PC-1.0, Repro-PC-1.0 polypeptides and methods for use in diagnosis and therapy.
    Type: Grant
    Filed: October 4, 2000
    Date of Patent: May 31, 2005
    Assignee: Diagnostic Products Corporation
    Inventors: Cynthia K. French, Karen K. Yamamoto, A. Said El Shami
  • Use of prothymosin in the diagnosis and treatment of endometriosis
    Patent number: 6753138
    Abstract: Prothymosin expression is up-regulated in endometriotic tissue. This invention provides methods of diagnosing endometriosis by detecting up-regulation of a prothymosin gene product, and methods of treating endometriosis by down-regulating expression of prothymosin in ectopic or eutopic endometriotic tissue.
    Type: Grant
    Filed: December 27, 2000
    Date of Patent: June 22, 2004
    Assignee: Reprogen, Inc.
    Inventors: Patrick A. Schneider, Cynthia K. French, Karen K. Yamamoto
  • Use of prothymosin in the diagnosis and treatment of endometriosis
    Publication number: 20040096884
    Abstract: Prothymosin expression is up-regulated in endometriotic tissue. This invention provides methods of diagnosing endometriosis by detecting up-regulation of a prothymosin gene product, and methods of treating endometriosis by down-regulating expression of prothymosin in ectopic or eutopic endometriotic tissue.
    Type: Application
    Filed: September 2, 2003
    Publication date: May 20, 2004
    Inventors: Patrick A. Schneider, Cynthia K. French, Karen K. Yamamoto
  • Method for identifying hormonally modulated genes
    Publication number: 20030033614
    Abstract: This invention provides methods of identifying hormone-regulated traits in a cell. The methods involve cultivating the cell as a graft in two different hormonal environments and determining whether expression of the trait differs in the two grafts.
    Type: Application
    Filed: September 17, 2001
    Publication date: February 13, 2003
    Inventors: Cynthia K. French, Karen K. Yamamoto
  • Endometriosis mouse model
    Patent number: 6429353
    Abstract: The invention provides an endometriosis mouse model wherein severely compromised immune deficient (SCID) female mice are transplanted with human xenografts of normal endometrial tissue, but result in mice with human endometriosis. Typically, the xenografts are treated with a micronized estrogen source prior to transplantation or implantation and the endogenous progesterone of the mice is eliminated also prior to transplantation of the human xenograft. These diseased mice are useful in the study of endometriosis.
    Type: Grant
    Filed: March 25, 1998
    Date of Patent: August 6, 2002
    Assignees: Reprogen, Inc., The Trustees of the Universiy of Pennsylvania
    Inventors: Jeffrey Boyd, Jerome J. Strauss, Peter Van Deerlin, Karen K. Yamamoto
  • ENDOMETRIOSIS MOUSE MODEL
    Publication number: 20020066116
    Abstract: The invention provides an endometriosis mouse model wherein severely compromised immune deficient (SCID) female mice are transplanted with human xenografts of normal endometrial tissue, but result in mice with human endometriosis. Typically, the xenografts are treated with a micronized estrogen source prior to transplantation or implantation and the endogenous progesterone of the mice is eliminated also prior to transplantation of the human xenograft. These diseased mice are useful in the study of endometriosis.
    Type: Application
    Filed: March 25, 1998
    Publication date: May 30, 2002
    Inventors: JEFFREY BOYD, JEROME J. STRAUSS, PETER VAN DEERLIN, KAREN K. YAMAMOTO
  • Use of cathepsin S in the diagnosis and treatment of endometriosis
    Patent number: 6387629
    Abstract: Cathepsin S expression is up-regulated in endometriotic tissue. This invention provides methods of diagnosing endometriosis by detecting up-regulation of a cathepsin S gene product, and methods of treating endometriosis by down-regulating expression of cathepsin S in ectopic or eutopic endometriotic tissue.
    Type: Grant
    Filed: March 26, 2001
    Date of Patent: May 14, 2002
    Assignee: Reprogen, Inc.
    Inventors: Patrick Schneider, Karen K. Yamamoto, Cynthia K. French
  • Prostate cancer-specific marker
    Patent number: 6218523
    Abstract: This invention provides cDNA encoding a prostate-cancer specific marker, Repro-PC-1.0, Repro-PC-1.0 polypeptides and methods for use in diagnosis and therapy.
    Type: Grant
    Filed: March 6, 1998
    Date of Patent: April 17, 2001
    Assignee: Diagnostic Products Corporation
    Inventors: Cynthia K. French, Patrick A. Schneider, Karen K. Yamamoto
  • HP-8 autoantigen
    Patent number: 5807993
    Abstract: An autoantigen identified as HP-8 which is related to systemic lupus erythematosus. The HP-8 antigen is expressed by a gene which was identified by immunoscreening of human placental cDNA GT11 expression library with the monoclonal antibody 3E10. The 3E10 antibody is a low-affinity anti-double-stranded DNA autoantibody derived from the MRL murine models for human systemic lupus erythematosus.
    Type: Grant
    Filed: April 12, 1995
    Date of Patent: September 15, 1998
    Assignee: VivoRx Autoimmune, Inc.
    Inventors: Cynthia K. French, Karen K. Yamamoto, Phoebe M. Chow, Negemias T. Alido